A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19) First published 07/10/2021 Last updated 03/11/2026 EU PAS number:EUPAS43556 Study Finalised